PubRank

Manuel Bardiès

Author PubWeight™ 24.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies. J Nucl Med 2010 1.45
2 Clinical radioimmunotherapy--the role of radiobiology. Nat Rev Clin Oncol 2011 1.10
3 Dosimetry is alive and well. Cancer Biother Radiopharm 2010 1.07
4 Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electrons. Radiat Res 2008 1.00
5 Radiolabeled antibodies for cancer imaging and therapy. Methods Mol Biol 2012 0.95
6 Monte Carlo modeling of gamma cameras for I-131 imaging in targeted radiotherapy. Cancer Biother Radiopharm 2005 0.94
7 Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a review. Eur J Nucl Med Mol Imaging 2011 0.93
8 Dosimetric impact of correcting count losses due to deadtime in clinical radioimmunotherapy trials involving iodine-131 scintigraphy. Cancer Biother Radiopharm 2003 0.93
9 Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide. Eur J Nucl Med Mol Imaging 2011 0.93
10 Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial. Clin Cancer Res 2003 0.91
11 Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapy. Cancer 2010 0.90
12 Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients. Tumour Biol 2012 0.88
13 Effect of patient morphology on dosimetric calculations for internal irradiation as assessed by comparisons of Monte Carlo versus conventional methodologies. J Nucl Med 2009 0.87
14 Impact of scatter and attenuation corrections for iodine-131 two-dimensional quantitative imaging in patients. Cancer Biother Radiopharm 2003 0.86
15 Treatment planning in molecular radiotherapy. Z Med Phys 2013 0.85
16 OEDIPE: a personalized dosimetric tool associating voxel-based models with MCNPX. Cancer Biother Radiopharm 2005 0.85
17 Apoptosis and p53 are not involved in the anti-tumor efficacy of ¹²⁵I-labeled monoclonal antibodies targeting the cell membrane. Nucl Med Biol 2013 0.84
18 Internal dosimetry with the Monte Carlo code GATE: validation using the ICRP/ICRU female reference computational model. Phys Med Biol 2017 0.81
19 Kinetic model analysis for absorbed dose calculation applied to brain in [¹⁸F]-fluorodeoxyglucose positron emission tomography imaging. Cancer Biother Radiopharm 2010 0.80
20 dAcquisition setting optimization and quantitative imaging for 124I studies with the Inveon microPET-CT system. EJNMMI Res 2012 0.79
21 Calculating an estimate of tissue integrated activity in 18F-FDG PET imaging using one SUV value. EJNMMI Res 2013 0.78
22 Comparison of four scatter correction methods for patient whole-body imaging during therapeutic trials with iodine-131. Cancer 2002 0.78
23 Comparison of electron dose-point kernels in water generated by the Monte Carlo codes, PENELOPE, GEANT4, MCNPX, and ETRAN. Cancer Biother Radiopharm 2009 0.78
24 Defining the role for dosimetry and radiobiology in combination therapies. Eur J Nucl Med Mol Imaging 2013 0.78
25 Optimized radioiodine therapy for Graves' disease: two MIRD-based models for the computation of patient-specific therapeutic 131I activity. Nucl Med Commun 2006 0.78
26 Improved realism of hybrid mouse models may not be sufficient to generate reference dosimetric data. Med Phys 2013 0.77
27 Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail. Eur J Nucl Med Mol Imaging 2012 0.77
28 Implementing dosimetry in GATE: dose-point kernel validation with GEANT4 4.8.1. Cancer Biother Radiopharm 2007 0.76
29 A fast method for rescaling voxel S values for arbitrary voxel sizes in targeted radionuclide therapy from a single Monte Carlo calculation. Med Phys 2013 0.75
30 Tandem myeloablative 131I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patients. Immunotherapy 2013 0.75
31 Implementation of a microdosimetric model for radioimmunotherapeutic alpha emitters. Cancer Biother Radiopharm 2007 0.75
32 Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders: real life experience and predictive factors of functional response. Nucl Med Commun 2017 0.75
33 Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details. J Nucl Med 2017 0.75
34 Accelerated GPU based SPECT Monte Carlo simulations. Phys Med Biol 2016 0.75